UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review of trials currently testing treatment and prevention of COVID-19

Clinical microbiology and infection, 2020-08, Vol.26 (8), p.988-998

2020

Volltextzugriff (PDF)

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

CPT: pharmacometrics and systems pharmacology, 2017-02, Vol.6 (2), p.87-109

2017

Volltextzugriff (PDF)

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Clinical pharmacology and therapeutics, 2014-08, Vol.96 (2), p.133-135

2014

Volltextzugriff (PDF)

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Journal of antimicrobial chemotherapy, 2020-08, Vol.75 (8), p.2334-2343

2020

Volltextzugriff (PDF)

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Journal of antimicrobial chemotherapy, 2020-12, Vol.75 (12), p.3611-3618

2020

Volltextzugriff (PDF)

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

European journal of clinical pharmacology, 2019-04, Vol.75 (4), p.519-528

2019

Volltextzugriff (PDF)

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

CPT: pharmacometrics and systems pharmacology, 2014-12, Vol.3 (12), p.1-4

Mentré, F

2014

Volltextzugriff (PDF)

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

Clinical pharmacology and therapeutics, 2012-02, Vol.91 (2), p.234-242

2012

Volltextzugriff (PDF)

The ISoP Standards and Best Practices Committee

Clinical pharmacology and therapeutics, 2014-06, Vol.95 (6), p.581-582

2014

Volltextzugriff (PDF)

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Clinical pharmacology and therapeutics, 2014-11, Vol.96 (5), p.599-608

2014

Volltextzugriff (PDF)

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

CPT: pharmacometrics and systems pharmacology, 2013-06, Vol.2 (6), p.1-2

2013

Volltextzugriff (PDF)

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

The European respiratory journal, 2012-03, Vol.39 (3), p.772-775

2012

Volltextzugriff (PDF)

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Journal of Epidemiology and Population Health, 2024-05, Vol.72

2024

Volltextzugriff (PDF)

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Journal of Epidemiology and Population Health, 2024-05, Vol.72, p.202401, Article 202401

2024

Volltextzugriff (PDF)

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

CPT: pharmacometrics and systems pharmacology, 2014-04, Vol.3 (4), p.1-9

2014

Volltextzugriff (PDF)

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Clinical pharmacology and therapeutics, 2012-05, Vol.91 (5), p.777-786

2012

Volltextzugriff (PDF)

Best Practices in Population Modeling Should Always Be Evolving

CPT: pharmacometrics and systems pharmacology, 2013-07, Vol.2 (7), p.1-2

2013

Volltextzugriff (PDF)

846 CHARACTERIZATION OF THE EARLY VIRAL KINETICS IN COMPENSATED CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS TREATED WITH BOCEPREVIR AND TELAPREVIR

Journal of hepatology, 2013-04, Vol.58, p.S347-S347

2013

Volltextzugriff (PDF)

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Antimicrobial agents and chemotherapy, 2023-05, Vol.67 (5), p.e0233918-e0233918

2023

Volltextzugriff (PDF)

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

CPT: pharmacometrics and systems pharmacology, 2015-06, Vol.4 (6), p.316-319

2015

Volltextzugriff (PDF)

Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome

CPT: pharmacometrics and systems pharmacology, 2013-07, Vol.2 (7), p.1-9

2013

Volltextzugriff (PDF)

A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

CPT: pharmacometrics and systems pharmacology, 2015-01, Vol.4 (1), p.37-40

2015

Volltextzugriff (PDF)

FC13-11 - Effectiveness of mazindol in children with ADHD : open-label study

European psychiatry, 2011, Vol.26 (S2), p.1892-1892

2011

Volltextzugriff (PDF)

Prédictions individuelles dynamiques en analyse conjointe avec un modèle non linéaire à effets mixtes et un processus de survie à risques compétitifs : application à des patients admis en réanimation pour sepsis

Revue d'épidémiologie et de santé publique, 2022-05, Vol.70, p.S91-S92

2022

Volltextzugriff (PDF)

Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak

Revue d'épidémiologie et de santé publique, 2021-06, Vol.69, p.S33-S33

2021

Volltextzugriff (PDF)

1 – 25 von 169

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect Journals

KollektionTaylor & Francis:Master (3349 titles)

ThemaAdult

ThemaPhysical Sciences

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(147)
Mit Volltextzugriff
(146)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(60)
Life Sciences & Biomedicine
(58)
Humans
(39)
Pharmacology & Pharmacy
(39)
Biological And Medical Sciences
(33)
Medical Sciences
(32)
Pharmacology. Drug Treatments
(25)
Pharmacokinetics
(22)
Female
(17)
Life Sciences
(17)
Male
(15)
Models, Biological
(13)
Exact Sciences And Technology
(12)
Software
(12)
Condensed Matter: Structure, Mechanical And Thermal Properties
(11)
Inorganic Compounds
(11)
Physics
(11)
Population
(11)
Structure Of Solids And Liquids; Crystallography
(11)
Structure Of Specific Crystalline Solids
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Review of trials currently testing treatment and prevention of COVID-19

Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics

The Use of Model-Based Tumor-Size Metrics to Predict Survival

Mortality in Escherichia coli bloodstream infections: antibiotic resistance still does not make it

Population pharmacokinetics and dosing simulations of amoxicillin in obese adults receiving co-amoxiclav

Population pharmacokinetic modeling of sustained release lithium in the serum, erythrocytes and urine of patients with bipolar disorder

Lewis Sheiner ISoP/UCSF Lecturer Award: From Drug Use to Statistical Models and Vice Versa

Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling

The ISoP Standards and Best Practices Committee

A Pharmacokinetic-Viral Kinetic Model Describes the Effect of Alisporivir as Monotherapy or in Combination With Peg-IFN on Hepatitis C Virologic Response

Current Use and Developments Needed for Optimal Design in Pharmacometrics: A Study Performed Among DDMoRe's European Federation of Pharmaceutical Industries and Associations Members

Octreotide treatment of idiopathic pulmonary fibrosis: a proof-of-concept study

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

CO1.2 - La randomisation distributive : un nouveau schéma d'essai pour l'évaluation simultanée d'interventions

Powers of the Likelihood Ratio Test and the Correlation Test Using Empirical Bayes Estimates for Various Shrinkages in Population Pharmacokinetics

Pharmacokinetic and Pharmacodynamic Variability of Fluindione in Octogenarians

Best Practices in Population Modeling Should Always Be Evolving

846 CHARACTERIZATION OF THE EARLY VIRAL KINETICS IN COMPENSATED CIRRHOTIC TREATMENT-EXPERIENCED PATIENTS TREATED WITH BOCEPREVIR AND TELAPREVIR

Pharmacokinetic Model of Tenofovir and Emtricitabine and Their Intracellular Metabolites in Patients in the ANRS 134-COPHAR 3 Trial Using Dose Records

Pharmacometrics Markup Language (PharmML): Opening New Perspectives for Model Exchange in Drug Development

Influence of a priori Information, Designs, and Undetectable Data on Individual Parameters Estimation and Prediction of Hepatitis C Treatment Outcome

A Model‐Based Illustrative Exploratory Approach to Optimize the Dosing of Peg‐IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy

FC13-11 - Effectiveness of mazindol in children with ADHD : open-label study

Prédictions individuelles dynamiques en analyse conjointe avec un modèle non linéaire à effets mixtes et un processus de survie à risques compétitifs : application à des patients admis en réanimation pour sepsis

Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak

Aktive Filter

Suchergebnisse filtern